Aline Guillot
42270 St Priest En Jarez
Sete, 42270, France
Sete, 42270, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
First Real-World Data of Olaparib Combination Treatment with Abiraterone and Prednisone or Prednisolone in First-Line Metastatic Castration-Resistant Prostate Cancer (mCRPC): Descriptive Analysis of 154 Patients Enrolled in the Early Access Program in France.
Journal: Drugs - real world outcomes
Published: March 26, 2026
Patient Versus Clinician Reported Symptoms Agreement in Advanced Metastatic Bladder Cancer Patients.
Patient Versus Clinician Reported Symptoms Agreement in Advanced Metastatic Bladder Cancer Patients.
Journal: Cancer medicine
Published: October 20, 2024
A Prospective Non-interventional Real-World Study of cabozantinib in Pretreated Patients With Advanced Renal Cell Carcinoma Refractory to Vascular Endothelial Growth Factor-Targeted Therapy (CASSIOPE).
Journal: Clinical genitourinary cancer
Published: September 02, 2024
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study.
Journal: The Lancet. Oncology
Published: June 08, 2023
The Impact of an Enrolment in Clinical Trial on Tolerance and Pathological Response for Patients Treated by Neoadjuvant MVAC Against an Invasive Bladder Cancer. A Retrospective Comparative Study.
Journal: Clinical genitourinary cancer
Published: March 13, 2023
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of the GETUG-AFU V05 VESPER Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 07, 2022
The Anti-Nectin 4: A Promising Tumor Cells Target. A Systematic Review.
Journal: Molecular cancer therapeutics
Published: October 19, 2021
TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate Cancer.
Journal: Clinical genitourinary cancer
Published: June 15, 2021
Second-generation hormonotherapy in prostate cancer and bone microenvironment.
Journal: Endocrine-related cancer
Published: April 13, 2021
Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) Trial.
Journal: Clinical genitourinary cancer
Published: February 20, 2021
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 Study.
Journal: Clinical genitourinary cancer
Published: December 17, 2020
Last Updated: 09/26/2026